Genetic Technologies launches novel risk assessment test covering 100% risk of breast and ovarian cancer
Genomics-based biotech Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, OTC:GNTLF) has released its novel Comprehensive Risk Assessment test, which...